Literature DB >> 25998938

Induction of fetal demise before pregnancy termination: practices of family planning providers.

Colleen C Denny1, Michele B Baron2, Lauren Lederle2, Eleanor A Drey3, Jennifer L Kerns3.   

Abstract

OBJECTIVES: Our survey aimed to characterize the practice of inducing fetal demise before pregnancy termination among abortion providers, including its technical aspects and why providers have chosen to adopt it. STUDY
DESIGN: We conducted a survey of Family Planning Fellowship-trained or Fellowship-affiliated Family Planning (FP) subspecialists about their practice of inducing fetal demise, including questions regarding the circumstances in which they would induce demise, techniques used and rationales for choosing whether to adopt this practice.
RESULTS: Of the 169 FP subspecialists we surveyed, 105 (62%) responded. About half (52%) of respondents indicated that they routinely induced fetal demise before terminations in the second trimester. Providers' practices varied in the gestations at which they started inducing demise as well as the techniques used. Respondents provided legal, technical and psychological reasons for their decisions to induce demise.
CONCLUSION: Inducing fetal demise before second-trimester abortions is common among US FP specialists for multiple reasons. The absence of professional guidelines or robust data may contribute to the variance in the current practice patterns of inducing demise. IMPLICATIONS: Our study documents the widespread practice of inducing fetal demise before second-trimester abortion and further describes wide variation in providers' methods and rationales for inducing demise. It is important for abortion providers as a professional group to come to a formal consensus on the appropriate use of these techniques and to determine whether such practices should be encouraged, tolerated or even permitted.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abortion; Dilation and evacuation; Fetal demise; Second-trimester termination

Mesh:

Year:  2015        PMID: 25998938      PMCID: PMC4540638          DOI: 10.1016/j.contraception.2015.05.002

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  13 in total

1.  Feticidal digoxin injection before dilation and evacuation abortion: evidence and ethics.

Authors:  David A Grimes; Gretchen S Stuart; Elizabeth G Raymond
Journal:  Contraception       Date:  2011-05-26       Impact factor: 3.375

2.  Infection and extramural delivery with use of digoxin as a feticidal agent.

Authors:  Rachel Steward; Alexander Melamed; Renita Kim; Deborah Nucatola; Mary Gatter
Journal:  Contraception       Date:  2011-02-21       Impact factor: 3.375

3.  Changes in abortion provider practices in response to the Partial-Birth Abortion Ban Act of 2003.

Authors:  Lisa Haddad; Susan Yanow; Laurent Delli-Bovi; Kate Cosby; Tracy A Weitz
Journal:  Contraception       Date:  2009-01-17       Impact factor: 3.375

4.  Abortion incidence and access to services in the United States, 2008.

Authors:  Rachel K Jones; Kathryn Kooistra
Journal:  Perspect Sex Reprod Health       Date:  2011-01-10

5.  Digoxin to facilitate late second-trimester abortion: a randomized, masked, placebo-controlled trial.

Authors:  R A Jackson; V L Teplin; E A Drey; L J Thomas; P D Darney
Journal:  Obstet Gynecol       Date:  2001-03       Impact factor: 7.661

6.  Abortion incidence and service availability in the United States, 2011.

Authors:  Rachel K Jones; Jenna Jerman
Journal:  Perspect Sex Reprod Health       Date:  2014-02-03

7.  Cardiac puncture of fetus with Hurler's disease avoiding abortion of unaffected co-twin.

Authors:  A Aberg; F Mitelman; M Cantz; J Gehler
Journal:  Lancet       Date:  1978-11-04       Impact factor: 79.321

8.  A randomized pilot study on the effectiveness and side-effect profiles of two doses of digoxin as fetocide when administered intraamniotically or intrafetally prior to second-trimester surgical abortion.

Authors:  Deborah Nucatola; Nitzan Roth; Mary Gatter
Journal:  Contraception       Date:  2010-01       Impact factor: 3.375

9.  Outpatient abortion for fetal anomaly and fetal death from 15-34 menstrual weeks' gestation: techniques and clinical management.

Authors:  W M Hern; C Zen; K A Ferguson; V Hart; M V Haseman
Journal:  Obstet Gynecol       Date:  1993-02       Impact factor: 7.661

10.  Transvaginal administration of intraamniotic digoxin prior to dilation and evacuation.

Authors:  Aileen M Gariepy; Beatrice A Chen; Heather L Hohmann; Sharon L Achilles; Jennefer A Russo; Mitchell D Creinin
Journal:  Contraception       Date:  2012-09-07       Impact factor: 3.375

View more
  2 in total

1.  Drugs used to induce fetal demise prior to abortion: a systematic review.

Authors:  Tesfaye H Tufa; Sarah Prager; Antonella F Lavelanet; Caron Kim
Journal:  Contracept X       Date:  2020-11-09

2.  Effectiveness of intra-cardiac lidocaine and intra-amniotic digoxin at inducing fetal demise before second trimester abortion past 20 weeks at a tertiary Hospital in Ethiopia: A retrospective review.

Authors:  Abraham Fessehaye Sium; Tesfaye H Tufa; Jaclyn M Grentzer; Sarah Prager
Journal:  Contracept X       Date:  2022-07-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.